Details of the Drug Reposition

General Information of This Drug (ID: DML8S0W)

Drug Name
MEDI6570   DML8S0W
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cardiovascular disease DIS2IQDX BA00-BE2Z Phase 2 [1]
Coronary heart disease DIS5OIP1 BA80.Z Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04610892) A Phase IIB, Randomized, Double Blinded, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants With a Prior Myocardial Infarction and Persistent Inflammation. U.S.National Institutes of Health.